Exclusive: Lilly-backed OrsoBio raises $67M for slate of obesity drugs as combinations take root

California biotech startup OrsoBio is betting the future of obesity drugs lies in combination approaches.

To get there, OrsoBio told Endpoints News that it raised …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Novel therapy harnesses stem cell-derived exosomes for diabetic wound healing

Researchers unveiled a novel therapy for diabetic wound healing. This research highlights the use of exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells (BMSCs)

February 20, 2024

Psychedelics Companies Reeling After FDA Vote | Psychedelic Invest

Here’s what investors need to know. Shares of prominent psychedelics companies, including Compass Pathways, Atai Life Sciences, and Mind Medicine, experienced a significant decline following

June 10, 2024

Nanostring files for bankruptcy protection, explores possible sale

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Nanostring Technologies, a maker of

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.